Abstract
We developed a first-of-kind dasatinib-derivative imaging agent, F-18-SKI-249380 (F-18-SKI), and validated its use for noninvasive in vivo tyrosine ki......
小提示:本篇文献需要登录阅读全文,点击跳转登录